Basic Information
Since its establishment nearly two years ago, Wuhan NewPets Biotechnology Co., Ltd. has experienced rapid development and achieved fruitful results. It has delivered over a thousand high-quality laboratory animals, supported three enterprises in completing the reinspection of the trivalent cat vaccine, evaluated the efficacy of dozens of innovative pet medicines, and collaborated with multiple institutions, including Shanghai Jiao Tong University, to establish two local standards. The company's highly efficient team, strong technical reserves, and resource integration capabilities are the cornerstones of building long-term and differentiated competitive advantages, earning high recognition from the industry and institutions.